MELPHALAN plus PREDNISONE vs MELPHALAN plus PREDNISONE plus THALIDOMIDE IN INDUCTION THERAPY FOR MULTIPLE MYELOMA IN ELDERLY PATIENTS: FIRST INTERIM RESULTS OF THE DUTCH COOPERATIVE GROUP HOVON

被引：0
|
作者：
Wijermans, P. [1 ]
Schaafsma, M. [2 ]
Van Norden, Y. [3 ]
Ammerlaan, R. [3 ]
Sonneveld, P. [4 ]
Wittebol, S. [5 ]
Sinnige, H.
Huijgens, P. [6 ]
Kooy, M. van Marwijk
van der Griend, R. [7 ]
机构：
[1] Haga Hosp, The Hague, Netherlands
[2] Med Specrum Twente, Enschede, Netherlands
[3] HOVON Datactr, Rotterdam, Netherlands
[4] Erasmus MC, Rotterdam, Netherlands
[5] Meander Med Ctr, Amersfoort, Netherlands
[6] Free Univ Med Ctr, Amsterdam, Netherlands
[7] Diakonessen Hosp, Utrecht, Netherlands
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0440
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [1] Melphalan plus Prednisone Versus Melphalan plus Prednisone plus Thalidomide in Induction Therapy for Multiple Myeloma in Elderly Patients: Final Analysis of the Dutch Cooperative Group HOVON 49 Study
    Wijermans, P.
    Schaafsma, M.
    van Norden, Y.
    Ammerlaan, R.
    Wittebol, S.
    Sinnige, H.
    Zweegman, Sonja
    Kooi, M. van Marwijk
    Van der Griend, R.
    Lokhorst, H.
    Sonneveld, P.
    BLOOD, 2008, 112 (11) : 241 - 242
  • [2] Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
    Waage, Anders
    Gimsing, Peter
    Fayers, Peter
    Abildgaard, Niels
    Ahlberg, Lucia
    Bjorkstrand, Bo
    Carlson, Kristina
    Dahl, Inger Marie
    Forsberg, Karin
    Gulbrandsen, Nina
    Haukas, Einar
    Hjertner, Oyvind
    Hjorth, Martin
    Karlsson, Torbjorn
    Knudsen, Lene Meldgaard
    Nielsen, Johan Lanng
    Linder, Olle
    Mellqvist, Ulf-Henrik
    Nesthus, Ingerid
    Rolke, Jurgen
    Strandberg, Maria
    Sorbo, Jon Hjalmar
    Wisloff, Finn
    Juliusson, Gunnar
    Turesson, Ingemar
    BLOOD, 2010, 116 (09) : 1405 - 1412
  • [3] Bortezomib plus Melphalan and Prednisone for Multiple Myeloma
    Avvisati, Giuseppe
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (24): : 2613 - 2613
  • [4] Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled-trial
    Palumbo, A
    Bringhen, S
    Coravito, T
    Merla, E
    Capporella, V
    Callea, V
    Cangialosi, C
    Grasso, M
    Rossini, F
    Galli, M
    Catalano, L
    Zamagni, E
    Petrucci, MT
    De Stefano, V
    Ceccarelli, M
    Ambrosini, MT
    Avonto, I
    Falco, P
    Ciccone, G
    Liberati, AM
    Musto, P
    Boccadoro, M
    LANCET, 2006, 367 (9513): : 825 - 831
  • [5] The Cost-Effectiveness of Initial Treatment of Multiple Myeloma in the U.S. With Bortezomib Plus Melphalan and Prednisone Versus Thalidomide Plus Melphalan and Prednisone or Lenalidomide Plus Melphalan and Prednisone With Continuous Lenalidomide Maintenance Treatment
    Garrison, Louis P., Jr.
    Wang, Si-Tien
    Huang, Hui
    Ba-Mancini, Abbie
    Shi, Hongliang
    Chen, Kristina
    Korves, Caroline
    Dhawan, Ravinder
    Cakana, Andrew
    van de Velde, Helgi
    Corzo, Deyanira
    Duh, Mei Sheng
    ONCOLOGIST, 2013, 18 (01): : 27 - 36
  • [6] Combination chemotherapy vs melphalan plus prednisone as treatment for multiple myeloma
    Tanner, J
    Dunst, J
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (10) : 532 - 532
  • [7] Phase III Study of the Value of Thalidomide Added to Melphalan Plus Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma: The HOVON 49 Study
    Wijermans, Pierre
    Schaafsma, Martijn
    Termorshuizen, Fabian
    Ammerlaan, Rianne
    Wittebol, Shulamiet
    Sinnige, Harm
    Zweegman, Sonja
    Kooy, Marinus van Marwijk
    van der Griend, Rene
    Lokhorst, Henk
    Sonneveld, Pieter
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3160 - 3166
  • [8] A RANDOMIZED PHASE II STUDY (GISL-MM03 TRIAL) WITH ORAL MELPHALAN plus PREDNISONE (MP) VERSUS MELPHALAN, plus PREDNISONE plus THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA
    Sacchi, S.
    Marcheselli, R.
    Pozzi, S.
    Bari, A.
    Ciarcia, O.
    Masini, L.
    Lazzaro, A.
    Morabito, F.
    Fragasso, A.
    Di Renzo, N.
    Quarta, G.
    Buda, G.
    Musto, P.
    Vigliotti, M. L.
    Pastorini, A.
    Brugiatelli, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 384 - 384
  • [9] THALIDOMIDE PLUS MELPHALAN AND PREDNISONE FOR AUSTRALIAN PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA IS COST-EFFECTIVE WHEN COMPARED WITH MELPHALAN AND PREDNISONE ALONE
    Lourenco, De Abreu R.
    Colman, S.
    Lee, C.
    VALUE IN HEALTH, 2009, 12 (07) : A381 - A381
  • [10] Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
    San Miguel, Jesus F.
    Schlag, Rudolf
    Khuageva, Nuriet K.
    Dimopoulos, Meletios A.
    Shpilberg, Ofer
    Kropff, Martin
    Spicka, Ivan
    Petrucci, Maria T.
    Palumbo, Antonio
    Samoilova, Olga S.
    Dmoszynska, Anna
    Abdulkadyrov, Kudrat M.
    Schots, Rik
    Jiang, Bin
    Mateos, Maria-Victoria
    Anderson, Kenneth C.
    Esseltine, Dixie L.
    Liu, Kevin
    Cakana, Andrew
    van de Velde, Helgi
    Richardson, Paul G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (09): : 906 - 917
12345